Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training.
Yong CM, Abnousi F, Rzeszut AK, Douglas PS, Harrington RA, Mehran R, Grines C, Altin SE, Duvernoy CS; American College of Cardiology Women in Cardiology Leadership Council (ACC WIC); Society for Cardiovascular Angiography and Interventions Women in Innovations (SCAI WIN). Yong CM, et al. Among authors: abnousi f. JACC Cardiovasc Interv. 2019 Feb 11;12(3):219-228. doi: 10.1016/j.jcin.2018.09.036. Epub 2019 Jan 16. JACC Cardiovasc Interv. 2019. PMID: 30660463 Free article.
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Abnousi F, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL; CHAMPION PHOENIX Investigators. Abtan J, et al. Among authors: abnousi f. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1905-13. doi: 10.1016/j.jcin.2016.06.046. JACC Cardiovasc Interv. 2016. PMID: 27659566 Free article. Clinical Trial.
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.
Yong CM, Sundaram V, Abnousi F, Olivier CB, Yang J, Stone GW, Steg PG, Michael Gibson C, Hamm CW, Price MJ, Deliargyris EN, Prats J, White HD, Harrington RA, Bhatt DL, Mahaffey KW; CHAMPION PHOENIX Investigators. Yong CM, et al. Among authors: abnousi f. Clin Cardiol. 2019 Sep;42(9):797-805. doi: 10.1002/clc.23221. Epub 2019 Jun 29. Clin Cardiol. 2019. PMID: 31254472 Free PMC article.
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
Abnousi F, Sundaram V, Yong CM, Prats J, Deliargyris EN, Stone GW, Hamm CW, Steg PG, Gibson CM, White HD, Price MJ, Généreux P, Desai M, Yang L, Ding VY, Harrington RA, Bhatt DL, Mahaffey KW. Abnousi F, et al. Am Heart J. 2017 Jun;188:147-155. doi: 10.1016/j.ahj.2017.02.031. Epub 2017 Mar 6. Am Heart J. 2017. PMID: 28577670 Clinical Trial.
25 results